Major depressive disorder (MDD) is a serious mental health condition that impacts individuals of all ages, including children ...
Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and ...
Johnson & Johnson is ending the phase 3 VENTURA clinical development program evaluating aticaprant, a selective kappa receptor antagonist, as an adjunctive treatment for major depressive disorder (MDD ...
PsyPost on MSN8d
Metabolic signature of depression found in blood, revealing biological links to the disorderA large-scale study published in Molecular Psychiatry has uncovered a distinct pattern of biological changes in people with ...
MedPage Today on MSN4d
Chronic Pain Sufferers No Stranger to Depression and AnxietyAmong 347,468 individuals who had lived with persistent pain for over 3 months, clinical symptoms of depression and anxiety ...
Menopause can worsen symptoms of bipolar disorder. In rare cases, it may trigger bipolar disorder. Menopause is a factor when ...
Researchers have revealed neural circuits in the brainstem that are crucially involved in implementing decisions by controlling three fundamental behavioral states or strategies: perseverance, ...
Major depressive disorder with seasonal patterns, also known as seasonal affective disorder, causes symptoms similar to ...
TipRanks on MSN3d
Mind Medicine’s (MNMD) Recent Achievements Boosting StockMind Medicine ($MNMD) announced its Q4 financials and indicated it is making strides in developing innovative treatments for ...
WARREN — Beacon Light Behavioral Health System (BLBHS), an affiliate of Journey Health System, announced it is offering ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback